Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)
Clinical trial NCT06128447 · RECRUITING
Trial details
- NCT number
- NCT06128447
- Sponsor
- Zero Point Five Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-14
- Primary completion
- 2026-05-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.